VOYA Investment Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Sell |
|
|||||
|
2025
Q1 | $388K | Buy |
|
|||||
|
2024
Q4 | $228K | Buy |
|
|||||
|
2024
Q3 | $250K | Buy |
|
|||||
|
2024
Q2 | $196K | Buy |
|
|||||
|
2024
Q1 | $326K | Sell |
|
|||||
|
2023
Q4 | $456K | Sell |
|
|||||
|
2023
Q3 | $2.01M | Buy |
|
|||||
|
2023
Q2 | $3.7M | Buy |
|
|||||
|
2023
Q1 | $832K | Sell |
|
|||||
|
2022
Q4 | $766K | Hold |
|
|||||
|
2022
Q3 | $787K | Sell |
|
|||||
|
2022
Q2 | $2.58M | Buy |
|
|||||
|
2022
Q1 | $2.17M | Sell |
|
|||||
|
2021
Q4 | $2.83M | Buy |
|
|||||
|
2021
Q3 | $367K | Buy |
|
|||||
|
2021
Q2 | $468K | Buy |
|
|||||
|
2021
Q1 | $602K | Sell |
|
|||||
|
2020
Q4 | $722K | Sell |
|
|||||
|
2020
Q3 | $542K | Sell |
|
|||||
|
2020
Q2 | $384K | Sell |
|
|||||
|
2020
Q1 | $525K | Sell |
|
|||||
|
2019
Q4 | $1.37M | Sell |
|
|||||
|
2019
Q3 | $3.53M | Buy |
|
|||||
|
2019
Q2 | $4.56M | Sell |
|
|||||
|
2019
Q1 | $4.14M | Sell |
|
|||||
|
2018
Q4 | $2.65M | Sell |
|
|||||
|
2018
Q3 | $3.98M | Sell |
|
|||||
|
2018
Q2 | $4.65M | Sell |
|
|||||
|
2018
Q1 | $49.8M | Buy |
|
|||||
|
2017
Q4 | $2.81M | Buy |
|
|||||
|
2017
Q3 | $998K | Hold |
|
|||||
|
2017
Q2 | $1.28M | Buy |
|
|||||
|
2017
Q1 | $828K | Sell |
|
|||||
|
2016
Q4 | $8.2M | Sell |
|
|||||
|
2016
Q3 | $12.3K | Sell |
|
|||||
|
2016
Q2 | $10.8M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $327K | Hold |
|
|||||
|
2015
Q3 | $238K | Sell |
|
|||||
|
2015
Q2 | $484K | Buy |
|